source
- Europe’s drug pricing split: UK leans pro‑industry while Germany eyes cuts and higher feesEuropean nations are feeling mounting pressure to rein in drug prices, a trend that is reshaping the market for both manufacturers and patients across the continent. In the United Kingdom, lobbyin…
- Beren Therapeutics secures $300 million to fund rare disease drug launch ahead of FDA reviewBeren Therapeutics announced it has raised $300 million in new financing to support the development and launch of its rare disease therapy. The funding arrives as the company prepares for an FDA d…